Is influenza vaccination in asthma helpful?

Current Opinion in Allergy and Clinical Immunology

Volumn 5, Issue 1, 2005, Pages 65-70

  Bueving, Herman J ^a   Thomas, Siep ^a   Van Der Wouden, Johannes C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Asthma; Clinical effectiveness; Influenza vaccination

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE; TRIPLE VACCINE;

ASTHMA; BRONCHOSPASM; CLINICAL TRIAL; DISEASE EXACERBATION; EPIDEMIC; HUMAN; IMMUNIZATION; INFLUENZA; INFLUENZA VACCINATION; PRIORITY JOURNAL; PROTECTION; RESPIRATORY TRACT INFECTION; REVIEW;

EID: 12944286500     PISSN: 15284050     EISSN: None     Source Type: Journal    
DOI: 10.1097/00130832-200502000-00012     Document Type: Review

References (57)

1. Meier CR, Napalkov PN, Wegmuller Y, et al. Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis 2000; 19:834-842.
2. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003; 289:179-186. Large population-based study describing that mortality is associated with the circulation of both influenza and respiratory syncytial virus, and disproportionately affects the elderly. The authors stress the need for better vaccines.
3. Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995; 310:1225-1229.
4. Atmar RL, Guy E, Guntupalli KK, et al. Respiratory tract viral infections in inner-city asthmatic adults. Arch Intern Med 1998; 158:2453-2459.
5. Neuzil KM, Zhu Y, Griffin MR, et al. Burden of interpandemic influenza in children younger than 5 years: a 25-year prospective study. J Infect Dis 2002; 185:147-152.
6. Neuzil KM, Wright PF, Mitchel EF Jr, Griffin MR. The burden of influenza illness in children with asthma and other chronic medical conditions. J Pediatr 2000; 137:856-864.
7. Neuzil KM, Mellen BG, Wright PF, et al. The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000; 342:225-231.
8. Izurieta HS, Thompson WW, Kramarz P, et al., Influenza and the rates of hospitalization for respiratory disease among infants and young children. N Engl J Med 2000; 342:232-239.
9. Weigl JA, Puppe W, Schmitt HJ. The incidence of influenza-associated hospitalizations in children in Germany. Epidemiol Infect 2002; 129:525-533.
10. Influenza. Fact sheet No. 211 ed. WHO; 2004.
11. Eisner MD. Asthma and influenza vaccination. Chest 2003; 124:775-777. Excellent editorial summarizing the (lack of) evidence, the problems and possible reasons for low coverage of vaccination for asthma patients Interesting plea from the author to embrace the available indirect evidence for the probable benefits of influenza vaccination in asthma patients. He recalls the strong evidence for its safety and finds further trials unnecessary.
12. Nicholson KG, Snacken R, Palache AM. Influenza immunization policies in Europe and the United States. Vaccine 1995; 13:365-369.
13. van Essen GA, Palache AM, Forleo E, Fedson DS. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 2003; 21:1780-1785
14. Williams SG, Schmidt DK, Redd SC, et al. Key clinical activities for quality asthma care: recommendations of the National Asthma Education and Prevention Program. MMWR Recomm Rep 2003; 52:1-8. Practice-based summary for the implementation of preventive quality care for asthma; highlights 10 key activities.
15. Kramarz P, DeStefano F, Gargiullo PM, et al. Influenza vaccination in children with asthma in health maintenance organizations. Vaccine Safety Datalink Team. Vaccine 2000; 18:2288-2294.
16. Centers for Disease Control and Prevention (CDC). Public health and aging: influenza vaccination coverage among adults aged ≥50 years and pneumococcal vaccination coverage among adults aged > or =65 years: United States, 2002. MMWR Morb Mortal Wkly Rep 2003; 52:987-992.
17. Fiebach NH, Viscoli CM. Patient acceptance of influenza vaccination. Am J Med 1991; 91:393-400.
18. Fox JP, Cooney MK, Hall CE, Foy HM. Influenzavirus infections in Seattle families, 1975-1979. II: Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness. Am J Epidemiol 1982; 116:228-242.
19. Monto AS Koopman JS, Longini IM Jr. Tecumseh study of illness. XIII: Influenza infection and disease, 1976-1981. Am J Epidemiol 1985; 121: 811-822.
20. Sugaya N, Nerome K, Ishida M, et al. Efficacy of inactivated vaccine in preventing antigenically drifted influenza type A and well-matched type B. JAMA 1994; 272:1122-1126.
21. Bueving HJ, Bernsen RM, de Jongste JC, et al. Influenza vaccination in children with asthma: randomized double-blind placebo-controlled trial. Am J Respir Crit Care Med 2004; 169:488-493. Interesting randomized double-blind, placebo-controlled trial in children aged 6-18 years with asthma on the clinical effectiveness of influenza vaccination. The first study taking culture confirmed asthma exacerbations, based on symptom scores, as an endpoint. Study was set up to detect a 50% reduction in the number of asthma exacerbations. Confidence interval excludes a 35% reduction. Low influenza activity during the first season.
22. Belshe RB, Mendelman PM. Safety and efficacy of live attenuated, cold-adapted, influenza vaccine-trivalent. Immunol Allergy Clin North Am 2003; 23:745-767.
23. Hannoun C, Megas F, Piercy J. Immunogenicity and protective efficacy of influenza vaccination. Virus Res 2004; 103:133-138.
24. The American Lung Association Asthma Clinical Centers. The safety of inactivated influenza vaccine in adults and children with asthma. N Engl J Med 2001; 345:1529-1536.
25. Gates CJ, Jefferson TO, Bara AI, Rowe BH. Vaccines for preventing influenza in people with asthma. The Cochrane Database of Systematic Reviews 2003; Issue 4. Art. No. CD000364.pub2. DOI: 10.1002/14651858. CD000364.pub2. This high-quality, extensive, systematic review provides an overview of the best evidence available. No restrictions for language were used. Only randomized trials were included. No increase in asthma exacerbations immediately after vaccination was found. No firm evidence from controlled trials was found to support the adoption of universal vaccination in patients with asthma as a clinical policy.
26. Nicholson KG, Nguyen-Van-Tam JS, Ahmed AH, et al. Randomised placebo-controlled crossover trial on effect of inactivated influenza vaccine on pulmonary function in asthma. Lancet 1998; 351:326-331.
27. Chiu WJ, Kuo ML, Chen LC, et al. Evaluation of clinical and immunological effects of inactivated influenza vaccine in children with asthma. Pediatr Allergy Immunol 2003; 14:429-436.
28. Tata LJ, West J, Harrison T, et al. Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease? Thorax 2003; 58:835-839.
29. Bueving HJ, Bernsen RM, de Jongste JC, et al. Does influenza vaccination exacerbate asthma in children? Vaccine 2004; 23:91-96.
30. Chen YH, Liou SH, Chou CC, et al. Influenza and pneumococcal vaccination of the elderly in Taiwan. Vaccine 2004; 22:2806-2811. Interesting because of the older age group followed. Found no relation between asthma and pneumonia death rate in this age category.
31. Redding G, Walker RE, Hessel C, et al. Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J 2002; 21:44-48.
32. Bergen R, Black S, Shinefield H, et al. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr Infect Dis J 2004; 23:138-144. Interesting because of the new intranasal vaccine used and the observation of an increased risk of asthma/reactive airway disease in children younger than 36 months of age, which is of potential concern because children are a target group for this type of vaccine.
33. Miller RL, Cheng M, DiMango EA, et al. T-cell responses and hypersensitivity to influenza and egg antigens among adults with asthma immunized with the influenza vaccine. J Allergy Clin Immunol 2003; 112:606-608.
34. Erhart LM, Rangel MC, Lu PJ, Singleton JA. Prevalence and characteristics of children at increased risk for complications from influenza, United States, 2000. J Pediatr 2004; 144:191-195.
35. Ford ES, Mannino DM, Williams SG. Asthma and influenza vaccination: findings from the 1999-2001 National Health Interview Surveys. Chest 2003; 124:783-789. This study provides a broad overview of the (lack of) coverage of influenza vaccination in all age categories.
36. Daley MF, Barrow J, Pearson K, et al. Identification and recall of children with chronic medical conditions for influenza vaccination. Pediatrics 2004; 113:e26-e33.
37. Nunes B, Contreiras T, Falcao JM. [Influenza vaccination: coverage of Portuguese population from 1998/1999 to 2002/2003]. Rev Port Pneumol 2004; 10:115-123.
38. Kroneman MW, van Essen GA, Tacken MA, et al. Does a population survey provide reliable influenza vaccine uptake rates among high-risk groups? A case-study of The Netherlands. Vaccine 2004; 22:2163-2170.
39. Egede LE, Zheng D. Racial/ethnic differences in influenza vaccination coverage in high-risk adults. Am J Public Health 2003; 93:2074-2078.
40. Zimmerman RK, Nowalk MP, Bardella IJ, et al. Physician and practice factors related to influenza vaccination among the elderly. Am J Prev Med 2004; 26:1-10.
41. de Jong JC, Beyer WE, Palache AM, et al. Mismatch between the 1997/1998 influenza vaccine and the major epidemic A(H3N2) virus strain as the cause of an inadequate vaccine-induced antibody response to this strain in the elderly. J Med Virol 2000; 61:94-99.
42. Szefler SJ. The natural history of asthma and early intervention. J Allergy Clin Immunol 2002; 109:3549-3553.
43. Monto AS. Use of selective viral cultures to adjust nonvirologic endpoints in studies of influenza vaccine efficacy. Am J Epidemiol 2003; 158:312-315. Excellent invited commentary describing the pitfalls of research of influenza vaccine efficacy in a nutshell and stressing the importance of viral culturing related to illness as an endpoint.
44. Carlson RV, Boyd KM, Webb DJ. The revision of the Declaration of Helsinki: past, present and future. Br J Clin Pharmacol 2004; 57:695-713.
45. Hayden FG. Rhinovirus and the lower respiratory tract. Rev Med Virol 2004; 14:17-31.
46. Nichol KL. The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines. Vaccine 2003; 21:1769-1775.
47. Rothbarth PH, Kempen BM, Sprenger MJ. Sense and nonsense of influenza vaccination in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 151:1682-1685.
48. Demicheli V, Rivetti D, Deeks JJ, Jefferson TO. Vaccines for preventing influenza in healthy adults. The Cochrane Database of Systematic Reviews 2004; Issue 3. Art. No. CD001269.pub2. DOI: 10.1002/14651858. CD001269.pub2. Extensive systematic review of high quality. No restrictions for language were used. Only randomized trials of influenza vaccination in adults were included. It was concluded that influenza vaccines are effective in reducing serologically confirmed cases of influenza. However, they are not as effective in reducing cases of clinical influenza.
49. Ahmed AH, Nicholson KG, Nguyen-van Tam JS, Pearson JC. Effectiveness of influenza vaccine in reducing hospital admissions during the 1989-90 epidemic. Epidemiol Infect 1997; 118:27-33.
50. Kramarz P, DeStefano F, Gargiullo PM, et al. Does influenza vaccination prevent asthma exacerbations in children? J Pediatr 2001; 138:306-310.
51. Yap FH, Ho PL, Lam KF, et al. Excess hospital admissions for pneumonia, chronic obstructive pulmonary disease, and heart failure during influenza seasons in Hong Kong. J Med Virol 2004; 73:617-623. Intriguing because no association was found for influenza activity as an independent risk factor for admission rates in asthma.
52. Villari P, Manzoli L, Boccia A. Methodological quality of studies and patient age as major sources of variation in efficacy estimates of influenza vaccination in healthy adults: a meta-analysis. Vaccine 2004; 22:3475-3486.
53. Christy C, Aligne CA, Auinger P, et al. Effectiveness of influenza vaccine for the prevention of asthma exacerbations. Arch Dis Child 2004; 89:734-735. Interesting because of the totally unexpected findings in a retrospective cohort study of 800 children with asthma. After adjusting for other variables, the vaccine group had a significantly increased risk of asthma-related emergency department and clinic visits (odds ratio 1.9 and 3.4, respectively).
54. Smits AJ, Hak E, Stalman WA, et al. Clinical effectiveness of conventional influenza vaccination in asthmatic children. Epidemiol Infect 2002; 128: 205-211.
55. Quach C, Piche-Walker L, Platt R, Moore D. Risk factors associated with severe influenza infections in childhood: implication for vaccine strategy. Pediatrics 2003; 112:e197-e201.
56. Abadoglu O, Mungan D, Pasaoglu G, et al. Influenza vaccination in patients with asthma: effect on the frequency of upper respiratory tract infections and exacerbations. J Asthma 2004; 41:279-283. Nice and simple randomized, double-blind, placebo-controlled trial in adults. No effect on asthma exacerbations was found, even in the subgroup with severe asthma. No cultures were taken during exacerbations.
57. Hak E, Hoes AW, Grobbee DE, et al. Conventional influenza vaccination is not associated with complications in working-age patients with asthma or chronic obstructive pulmonary disease. Am J Epidemiol 2003; 157: 692-700. Large-scale study. First, the results were analysed in a nested case control design. No associations were found between influenza vaccination and reduction of complications. Second, application of a new method (propensity score) was performed to further remove confounding by indication. No association was found.